Allergan

Showing 15 posts of 142 posts found.

allergan_pfizer_logos

Pfizer in ‘friendly’ merger talks with Allergan

October 29, 2015
Sales and Marketing Actavis, Allergan, Pfizer, Teva

Pfizer is in talks with Allergan over what could be the largest takeover deal in an already record-breaking year, it …

allergan_ceo_bernie_saunders

Allergan axes 117 jobs in Kythera buyout

October 15, 2015
Allergan, Kythera

According to a notice filed with the state of California, Allergan will be laying off 117 employees at Kythera’s Westlake …

Allergan

Allergan recalls eye drugs after complaints of blurred vision

August 25, 2015
Manufacturing and Production Allergan, manufacturing, product recalls, production, recalls

Allergan has issued a recall for batches of eye ointments sold in the US, after customers complained of foreign bodies …

allergan

Teva to switch generics focus to Allergan

July 27, 2015
Sales and Marketing Allergan, Teva, generics, mergers and acquisitions, pharma mergers and acquisitions

Teva is in negotiations to buy Allergan’s generics division for upwards of $40 billion, according to reports. The generics firm …

Actavis facility in Iceland

Allergan closing manufacturing facility in Iceland

July 14, 2015
Manufacturing and Production Actavis, Allergan, Iceland, manufacturing, production, redundancies

Actavis is shutting a plant in Iceland, where its recently-acquired company Actavis has roots, and cutting 300 jobs in the …

Valeant image

Valeant looking to buy Zoetis

June 26, 2015
Sales and Marketing Actavis, Allergan, Valeant, Zoetis, brett wells

Canadian drugmaker Valeant Pharmaceuticals has made a move to acquire animal health company Zoetis. This is according to the Wall …

Allergan logo

Actavis changes its name to Allergan

June 16, 2015
Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Valeant

Actavis has now officially changed its name to Allergan following the Ireland-based company’s recent acquisition of the botox maker. This …

Roche logo

NICE signs-off Roche’s Gazyvaro for leukaemia

June 2, 2015
Sales and Marketing Allergan, Bayer, CLL, Carole Longson, Eylea, Gazyvaro, NICE, Ozurdex, Roche, diabetic macular edema, leukaemia

NICE has given positive final guidance backing the use of Roche’s Gazyvaro for people with chronic lymphocytic leukaemia (CLL). Earlier …

michael_r_gallagher_actavis

Actavis gains new Allergan directors

March 20, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Michael Gallagher, Peter McDonnell

Ireland, Dublin-based pharma firm Actavis has added former Allergan members Michael Gallagher and Dr Peter McDonnell to its board of …

Actavis image

Actavis buys generics firm for £306 million

January 26, 2015
Manufacturing and Production, Sales and Marketing Actavis, Allergan, Auden McKenzie, generics

Actavis is buying UK-based development and marketing firm Auden McKenzie in a deal worth up to £306 million. The move …

Valeant pharma

Valeant recalls drug used on hospitalised infants

January 6, 2015
Manufacturing and Production, Sales and Marketing Actavis, Allergan, FDA, Valeant, manufacturing, recall, ribavirin, virazole

North American drug firm Valeant Pharmaceuticals has issued a voluntary nationwide recall of Virazole due to microbial contamination. Virazole (ribavirin …

Actavis image

Actavis to axe 200 jobs

December 4, 2014
Medical Communications, Sales and Marketing Actavis, Allergan, Forest, GSK, Warner Chilcott, corona, stevenage

Actavis is set to cut 200 jobs in the US just weeks after buying Allergan for $66 billion. The lay-offs …

allergan image

Actavis buys Allergan for $66 billion

November 18, 2014
Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Canada, Valeant, merger

The stately dance between Actavis and Allergan has culminated in the former buying the Botox manufacturer in a $66 billion …

Allergan image

Allergan eyeing Actavis buyout

November 13, 2014
Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Botox, Valeant, acquisition, buyout, merger

Allergan is attempting to block a recent Valeant hostile takeover bid by seeking the rumoured alternative merger deal with Actavis, …

Allergan image

Allergan and Valeant trade blows as shareholder meeting looms

November 6, 2014
Sales and Marketing Actavis, Allergan, Forest, Valeant, merger, warner

Allergan’s efforts to block a key supporter of Valeant’s hostile takeover bid from voting at next month’s special shareholder meeting …

The Gateway to Local Adoption Series

Latest content